NorthWest Biotherapeutics Inc (NWBO)

[ROS-CH]

So, the gist of the last 100 posts or so is simple :

Almost EVERY BP-company (Roche, AZN, J&J, GSK, Amgen ...) must aquire NWBO because they all want to cure cancer (who not ?) and according to this board, NWBO has that cure.

The disconnect to above statement is NWBO's current SP of 0.52.

If only one BP would be SERIOUSLY looking @ NWBO, SP should be much much higher, simply because of the Biotech rumor-mill. Just take the recent aquisition of Alpine for more than $ 4 Bill. with one product in P II.

Can anyone explain ?